Funder: Cancer Research Institute
Due Dates: December 1, 2025 (Letter of Intent) | March 13, 2026 (Invited Full Proposal)
Funding Amounts: $300,000 over 2 years; possible renewal for an additional $300,000 over 2 years; up to 10% indirect costs provided in addition to award.
Summary: Supports translational cancer immunology research bridging laboratory discovery and clinical application, with direct patient relevance.
Key Information: Open to tenure-track assistant professors or higher at non-profit institutions worldwide; no citizenship restrictions.